Chlamydia pneumoniae infection: an additional factor for chronic allograft rejection

A Kwiatkowski1, M Wszola, R Nosek

  • 1Department of General and Transplantation Surgery, Warsaw Medical University, ul. Nowogrodzka 59, 02-006 Warsaw, Poland.

Insights

Chronic rejection in kidney transplants is a major challenge. This study found that Chlamydia pneumoniae DNA in leukocytes and abnormal lipid levels increase the risk of chronic rejection, suggesting a multifactorial prediction model.

Area of Science:

  • Transplantation immunology
  • Infectious disease in transplantation
  • Nephrology

Background:

  • Chronic rejection (CHR) remains a significant challenge in organ transplantation, with its underlying mechanisms not fully elucidated.
  • Understanding factors influencing late kidney transplant function is crucial for improving patient outcomes.

Purpose of the Study:

  • To investigate the influence of specific parameters on the development of chronic rejection in kidney allografts.
  • To identify potential predictors of late kidney transplant dysfunction.

Main Methods:

  • Analysis of 86 patients who received kidney allografts between 1988 and 1999.
  • Evaluation of parameters including Chlamydia pneumoniae DNA, lipid profiles, donor ischemic damage, and acute rejection episodes.
  • Application of multiple binary logistic regression and econometric modeling for multifactorial analysis.

Main Results:

  • The presence of Chlamydia pneumoniae DNA in peripheral blood leukocytes was significantly higher in patients with chronic rejection (46% vs 20%).
  • Patients with C. pneumoniae DNA had a higher incidence of CHR (50% vs 22%).
  • CHR(+) patients exhibited lower HDL and higher triglyceride levels compared to CHR(-) patients.

Conclusions:

  • The presence of Chlamydia pneumoniae DNA in leukocytes is associated with an increased risk of chronic kidney transplant rejection.
  • A multifactorial analysis incorporating parameters like C. pneumoniae DNA, perfusion methods, and lipid levels can predict the risk of CHR.
Abstract

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...